Compounded semaglutide from licensed 503A pharmacies follows strict stability guidelines that differ slightly from brand-name formulations
Abbreviations GLP-1RAs: Glucagon-like peptide 1 receptor agonists GLP-1: Glucagon-like peptide 1 ADRs: Adverse drug reactions SSIBs: Suicidal or self-injurious behaviors EMA: European Medicines Agency FDA: The Food and Drug Administration FAERS: The Food and Drug Administration Adverse Event Reporting System MedDRA: The Medical Dictionary for Regulatory Activities TTO: Time-to-onset CI: Confidence interval IC: Information Component References Lingvay I, Leiter LA
According to Yucca Health's safety information pages, the most common side effects include: Gastrointestinal Effects: Nausea (most common, especially early on) Diarrhea Constipation Vomiting Indigestion and abdominal discomfort Feeling full quickly after eating Other Common Effects: Headache Fatigue Dizziness Managing Side Effects: Most patients find that nausea and gastrointestinal symptoms improve as the body adjusts to the medication
When the 4-mg and 8-mg groups were combined, the weight loss averaged 12.9% and 17.3%, respectively [2]
Safety: 62% of participants reported treatment-emergent adverse events
The oral version of semaglutide for treating diabetes, under the trademark Rybelsus, was introduced in 2019, but you had to take it daily rather than a weekly injection